KCT0001977招募中未知
The effect of somatostatin for treatment of post hepatectomy liver failure (PHLF)
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- o Limit 至 o Limit（—）
- 性别
- All
入选标准
- •1. Patients with PHLF without regard primary disease.
- •2. Ability to provide written informed consent
排除标准
- •1. Concomitant surgery for another intraabdominal organs.
- •2. Severe renal disease requiring dialysis.
- •3. Patients with coagulation disorders or taking warfarin.
- •4. Immunosuppressed patients or the patients with autoimmune disorders.
- •5. Women with pregnant, breast-feeding.
- •6. Hypersensitivity to somatostatin.
- •7. Patients treated with other investigational product within 30 days at the consents are obtained.
- •8. Patients with a significantly reduced cognitive abilities.
- •9. Not eligible to participate for study at the discretion of investigator.
研究者
相似试验
进行中（未招募）
1 期
Research on the effectiveness of octreotide in Gastric Antral Vascular Ectasia (GAVE)in patients with anemia.Gastric Antral Vascular Ectasia (also known as watermelon stomach)EUCTR2020-004075-41-NLRadboudumc12
招募中
不适用
Effectiveness of Somatostatin Analogues in patients with Gastric Antral Vascular Ectasia and symptomatic gastrointestinal bleeding: SAGAVE Pilot studyNL-OMON21472Radboudumc12
招募中
2 期
Effectiveness of Somatostatin Analogues in patients with Gastric antral vascular ectasia and symptomatic gastrointestinal bleeding: SAGAVE-trial1) Gastric Antral Vascular Ectasia. 2) Watermelon stomach.10017959NL-OMON49336Radboud Universitair Medisch Centrum14
进行中（未招募）
1 期
The effectiveness of Octreotide in hereditary hemorrhagic telangiectasia (a.k.a. Rendu-Osler-Weber disease) patients who suffer from gastrointestinal bleeding.EUCTR2018-004179-11-NLRadboudumc38
尚未招募
不适用
Onderzoek naar de effectiviteit van octreotide in hereditary hemorrhagic telangiectasia patiënten metdaarbij gastrointestinale bloedingen.NL-OMON25382Radboudumc38